Cargando…
Lipofundin-Induced Hyperlipidemia Promotes Oxidative Stress and Atherosclerotic Lesions in New Zealand White Rabbits
Atherosclerosis represents a major cause of death in the world. It is known that Lipofundin 20% induces atherosclerotic lesions in rabbits, but its effects on serum lipids behaviour and redox environment have not been addressed. In this study, New Zealand rabbits were treated with 2 mL/kg of Lipofun...
Autores principales: | Delgado Roche, Livan, Acosta Medina, Emilio, Fraga Pérez, Ángela, Bécquer Viart, María A., Soto López, Yosdel, Falcón Cama, Viviana, Vázquez López, Ana M., Martínez-Sánchez, Gregorio, Fernández-Sánchez, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184413/ https://www.ncbi.nlm.nih.gov/pubmed/21977325 http://dx.doi.org/10.1155/2012/898769 |
Ejemplares similares
-
Smoflipid Is Better Than Lipofundin for Long-Term Neurodevelopmental Outcomes in Preterm Infants
por: Chen, I-Lun, et al.
Publicado: (2021) -
Lipofundin MCT/LCT Inhibits Levcromakalim-Induced Vasodilation by Inhibiting Endothelial Nitric Oxide Release
por: Lee, Soo Hee, et al.
Publicado: (2020) -
Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022) -
Pathophysiology of the atherosclerotic rabbit.
por: Lee, R J, et al.
Publicado: (1978) -
Several circulating miRNAs related to hyperlipidemia and atherosclerotic cardiovascular diseases
por: Xu, Jiang, et al.
Publicado: (2019)